CHEMEDIUM SIGNALFINANCIAL10-K

CHE significantly reduced debt and cash positions while maintaining aggressive share buyback activity, suggesting active capital structure optimization despite declining profitability.

The company appears to be executing a deliberate deleveraging strategy, reducing debt by 47% while simultaneously returning substantial capital to shareholders through increased buybacks. However, the 12% decline in net income combined with reduced cash reserves (down 58%) may indicate earnings pressure or reduced financial flexibility for future growth investments.

Comparing 2026-02-27 vs 2025-02-28View on EDGAR →
FINANCIAL ANALYSIS

CHE's financial profile shows a mixed picture of capital allocation priorities and operational challenges. While the company strengthened its balance sheet by reducing debt by $87.5M and maintained aggressive shareholder returns through $431.5M in buybacks, core profitability declined 12% to $265.2M and cash reserves dropped dramatically from $178.3M to $74.5M. The combination of reduced liquidity, higher capital expenditures, and lower earnings suggests the company may be prioritizing debt reduction and shareholder returns over maintaining financial flexibility, which could limit its ability to respond to growth opportunities or operational challenges.

FINANCIAL STATEMENT CHANGES
Cash & Equivalents
Balance Sheet
-58.2%
$178.3M$74.5M

Cash declined 58.2% — significant cash burn or deployment; verify adequacy of remaining liquidity runway.

Total Debt
Balance Sheet
-47.3%
$185.0M$97.5M

Debt reduced 47.3% — deleveraging strengthens balance sheet and reduces financial risk.

Capital Expenditure
Cash Flow
+26.8%
$49.5M$62.8M

Capex increased 26.8% — ongoing investment in capacity or infrastructure for future growth.

Current Assets
Balance Sheet
-23.3%
$394.7M$302.6M

Current assets declined 23.3% — monitor working capital adequacy and short-term liquidity.

Share Buybacks
Cash Flow
+19.4%
$361.4M$431.5M

Share repurchases increased 19.4% — management returning capital, signals confidence in intrinsic value.

Stockholders Equity
Balance Sheet
-12.5%
$1.1B$979.4M

Equity decreased 12.5% — buybacks or losses reducing book value, monitor solvency ratios.

Net Income
P&L
-12.2%
$302.0M$265.2M

Net income declined 12.2% — review whether driven by operations, interest costs, or non-recurring items.

LANGUAGE CHANGES
NEW — 2026-02-27
PRIOR — 2025-02-28
ADDED
On February 10, 2026, 13,765,136 shares of Chemed Capital Stock (par value $1 per share) were outstanding.
Management s Discussion and Analysis of Financial Condition and Results of Operations 28 Item.7A.
Approximately 20% of all hospice providers are not-for-profit.
Roto-Rooter s ability to engage in the plumbing repair, excavation and water restoration businesses is also subject to certain limitations and restrictions imposed by state and local licensing laws and regulations.
In the event that these Certificate of Need laws and similar restrictions are removed or their impact is weakened in any geography in which VITAS already operates, additional competitors may be able to enter those markets more easily, and potentially adversely affect VITAS.
+7 more — sign up free →
REMOVED
On February 10, 2025, 14,636,695 shares of Chemed Capital Stock (par value $1 per share) were outstanding.
Management s Discussion and Analysis of Financial Condition and Results of Operations 26 Item.7A.
Approximately one quarter of all hospice providers are not-for-profit.
In the event that these restrictions are removed or their impact is lessened in any geography in which VITAS already operates, additional competitors may more easily be able to enter those markets, and potentially adversely affect VITAS.
Reimbursement from state Medicaid programs in 2024 accounted for approximately 4% of VITAS revenues.
+7 more — sign up free →
MORE FINANCIAL SIGNALS
PNRGHIGHPNRG achieved exceptional profitability improvement with net income surging 2,21...
2026-04-16
BNAIHIGHBNAI underwent a dramatic reverse stock split that reduced share count by 86% wh...
2026-04-16
LAKEHIGHLAKE's financial performance deteriorated significantly with operating losses wo...
2026-04-16
NXXTHIGHNextNRG experienced massive financial deterioration with operating losses explod...
2026-04-16
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →